SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1427 Software, Thanks for sharing your notes with the thread. I couldn't ageee mVector1-4/20/2000
1426 4/19/00 conference call notes 1. financial guidance revenues: remains the samsoftware salesperson-4/20/2000
1425 <<but do INCY need to buy OGS ?>> No but it would be a good thing. Vector1-4/17/2000
1424 nig they did a placement of around 90 mœ iistead of 100 ar 19œ cheers stefaandalroi-4/17/2000
1423 Yes. I read somewhere about a week ago that they had scaled down an offering &anigel bates-4/17/2000
1422 Nigel, By CAT do you mean Cambridge Antibody Technology. I don't know whetVector1-4/16/2000
1421 How about CAT ? Didn't they fail to get a share issue out while the window nigel bates-4/16/2000
1420 Jim, It could be a great deal for both companies. It would firmly establish INCVector1-4/15/2000
1419 <Look for them to do some munching if things get weaker.> They will pickBiotech Jim-4/15/2000
1418 Dueche Bank Alex Brown led the PIPE. It was all bought by one institution, JanuVector1-4/15/2000
1417 Question for the thread..... INCY issued two million shares 2/23 at $211/sharscaram(o)uche-4/15/2000
1416 Thanks for the response. I agree. That much money signals the intent to do soLighthouse-4/11/2000
1415 >>Could it be that we will actually see some developments regarding this nigel bates-4/11/2000
1414 That is lot of money in regards to the historical operations of the joint ventuLighthouse-4/11/2000
1413 Some news at last on diaDexus - Tuesday April 11, 6:55 am Eastern Time Compannigel bates-4/11/2000
1412 Article re drug development time expedited by genomics : JNJ drug from INCY: qSteven Rachbach-4/10/2000
1411 Apologies in advance, but you guys have reminded me of an old skit where Don KnDoc Bones-4/9/2000
1410 Thanks Peter, The plot thickens. Agilent which also has a licence from SouthernVector1-4/7/2000
1409 AFFX loses against OGT on the Southern patent. This is very significant for boBiomaven-4/7/2000
1408 Scott, I agree on MLNM. I am not positive on Curagen. I do not have a strong viVector1-3/30/2000
1407 <<IMO the market is not able to distinguish the winners from the losers.&scott_jiminez-3/30/2000
1406 Scott, thanks for the link. Interesting analysis. IMO the market is not able toVector1-3/30/2000
1405 <<<BTW, Janus paid over $200/share less than 6 weeks ago>>> scott_jiminez-3/30/2000
1404 Useful link for anyone at CBS Marketwatch.... sec.gov nignigel bates-3/30/2000
1403 Janus bought its shares in the PIPE. The deal is they buy discounted common shaVector1-3/30/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News